Vitamin D Testing Market by Product, End-user and Geography - Forecast and Analysis 2023-2027

Vitamin D Testing Market Forecast 2023-2027

The global vitamin D testing market size is estimated to grow by USD 193.53 million at a CAGR of 5.44% between 2022 and 2027. 

One of the major reasons for the large-scale incidence of several nutritional disorders is lack of awareness. Promoting awareness among people about the importance of essential nutrients such as vitamin D which have a major role to play in improving health around the world is very important. One of the main growth drivers in market is increasing awareness. Various awareness programs run by the government and non-government organizations, educational campaigns about vitamin D sources, benefits, and consequences of its deficiency and insufficiency at the community level targeting both high-risk and general population have further enabled in preventing long-term health consequences. The increased awareness has also been made possible by an increase in internet penetration among end users. 

What will be the size of the Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Segmentation

The market caters to individuals concerned about their calcium, magnesium, and phosphate levels, often determined through methods like radioimmunoassay and HPLC. With reimbursement policies influencing access, testing is crucial, particularly given the prevalence of VDD (Vitamin D deficiency) resulting from sedentary lifestyles and inadequate sunlight exposure. Awareness campaigns highlight the importance of maintaining strong bones and teeth, especially in the face of serious and chronic diseases like Inflammatory Bowel Disease (IBD). As abnormal levels may indicate bone disorders or other medical conditions, accurate testing is essential to address potential organ damage and nutrition issues affecting tissues.

Technavio has segmented the market into Product, End-user, and Geography segments. 

• The Product segment is classified into 25-hydroxyvitamin D testing and 1 25-dihydroxy vitamin D testing 
• The End-user segment is classified into diagnostic laboratories, hospitals, physician clinics, and home care settings 
• The geography segment includes key regions such as North America, Europe, Asia, and the Rest of the World (ROW)

By Product

The market share growth by the 25-hydroxyvitamin D segment will be significant during the forecast period. One of the nutrients needed for human health is vitamin D, which helps to facilitate functions such as cell growth modulation, neuromuscular and immune function, or reduction in inflammation. Several genes encoding proteins that regulate cell differentiation, proliferation, and apoptosis are modulated in part by vitamin D.

Get a glance at the market contribution of various segments View a PDF Sample

The 25-hydroxyvitamin D segment was valued at USD 409.88 million in 2017.  Two bioequivalent forms of vitamin D, namely vitamin D2, known as ergocalciferol, are obtained from plant-based food sources and oral supplements. Vitamin D3, known as cholecalciferol, is released primarily through skin exposure to ultraviolet B (UVB) radiation found in sunlight and through the consumption of vitamin-rich foods such as fatty fish, fortified foods, and oral supplements. Various market players Various are offering innovative products to meet the end-users expectations.  The increasing prevalence of osteomalacia and rickets among children will drive the growth of the 25-hydroxyvitamin D testing segment of the market during the forecast period.

By End-User 

Diagnostic laboratories include independent testing laboratories and play an important role in the market by offering efficient services such as quantitative chemiluminescent immunoassay. These laboratories require robust and efficient testing instruments such as analyzers, spectroscopes, centrifuges, and liquid handling systems to obtain precise results as per the standards. Furthermore, vitamin D tests performed in diagnostic laboratories may use radioactive isotopes such as I-125 as tracers and require highly skilled laboratory professionals for effective laboratory management. A shortage of trained professionals poses a significant challenge and could negatively impact increased sales of laboratory-dedicated products. However, training of testing professionals mandated by agencies such as the Centers for Disease Control and Prevention (CDC) could overcome such problems and facilitate the rapid growth in the diagnostic testing sector during the forecast period.

The rising hospitals and physician clinics rate, due to prevalence of chronic conditions such as diabetes, rickets, and osteoporosis, has resulted in a rising number of procedures in hospitals and physician clinics, as vitamin D levels are closely related to such conditions. Moreover, rising access to acute care facilities owing to their growing number further aided in promoting in hospitals. Furthermore, the benefits of integrated care and personal consultations have increased the demand for vitamin D testing in clinics and are expected to boost the adoption of vitamin D testing in hospitals and physician clinics segment during the forecast period.

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The North American market has been led by the US due to the presence of numerous vendors such as Abbott, Danaher, and Quest Diagnostics Inc., which offer a wide range of vitamin D testing products in the region. According to the CDC, 25% of the US population is at risk of insufficient vitamin D, and 8% are at risk of deficiency, as defined by the Dietary Reference Intake (DRI) set by the Institute of Medicine. Similarly, the US Department of Agriculture (USDAs) National Nutrient Database highlights the nutrient content of a range of foods and provides an all-inclusive list of foods containing vitamin D arranged by the name of the food and its nutrient content.

Moreover, several studies have shown that vitamin D deficiency is a contributing factor to the development of type 1 and type 2 diabetes, with high rates of diabetes associated with low vitamin D levels in patients in this region. Furthermore, due to the increasing awareness about vitamin D testing, the e US is followed by Canada in terms of revenue contribution. For instance, the Vitamin D Society, a non-profit organization in Canada, works to grow awareness about many health conditions, which are linked to vitamin D deficiency, and encourage all the people in Canada to be proactive and get their vitamin D blood levels tested annually. All these factors are expected to drive the growth of the market in North America.

Buy Now Full Report and Discover More

Market Dynamics and Customer Landscape

The market plays a crucial role in assessing VDD (Vitamin D deficiency), a condition prevalent among individuals with sedentary lifestyles and limited sunlight exposure. With the rise in awareness campaigns and the incidence of serious and chronic diseases like Inflammatory Bowel Disease (IBD), demand for accurate vitamin D assessments is increasing. Diagnostic methods such as radioimmunoassay and HPLC aid in measuring calcium, magnesium, and phosphate levels, essential for maintaining strong bones and preventing bone disorders. Efficient testing is crucial to identify and address abnormal levels, reducing the risk of organ damage and associated medical conditions. There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key Market Drivers

The growing prevalence of vitamin D deficiency-related disorders is the key factor driving the growth of the market. Vitamin D deficiency is associated with serious health disorders such as rickets. Rickets is a disease in which bone tissue fails to mineralize properly, causing weak bones and skeletal deformities, especially in children. In addition, a growing number of research studies on vitamin D deficiency have been shown to be associated with several health problems. Low vitamin D levels in the blood are thought to increase the risk of cardiovascular disease, cognitive impairment in the elderly, severe asthma in children, and cancer.

Furthermore, healthcare professionals also routinely test people for vitamin D deficiency because of musculoskeletal symptoms, such as bone pain, muscle aches, and general weakness. Additionally, vitamin D deficiency is associated with an increased risk of diabetes, immune system disorders, and neuropsychiatric disorders. Thus, the association of vitamin D deficiency with several health-related disorders is expected to boost the market during the forecast period.

Significant Market Trends

A growing number of strategic developments by companies is the primary trend in the market. Market players are looking to expand their diagnostic and testing product portfolios through various inorganic growth strategies. M&A helps market players to focus on product innovation, grow profit margins through collaboration, and support technology sharing among players. Through the M&A, both companies will realize economies of scale through large-scale production and distribution, lowering unit prices for such products. As a result, companies like Abbott and bioMerieux are focused on growing product sales through mergers and acquisitions.

Moreover, remarkable M&A activity have been observed in the market. These activities will help the market players to grow and expand their global footprint and leverage existing distribution channels and customer relationships to better serve the needs of patients and caregivers. Thus, the growing number of M and A activities by major players will strengthen the diagnostic capabilities of the company, which will boost the growth of the market during the forecast period.

Major Market Challenges

Product recalls pose challenges to manufacturers that affect the growth of the market. Product recalls impacting on both consumer confidence and a company's brand image, thus impacting both a company's revenue and long-term prospects. This, in turn, affects product sales. Such product recalls hinder the product innovation process of manufacturers and allow competitors to accelerate their innovation efforts to exploit these weaknesses. Timely innovation gives companies a significant advantage in the competitive market.

Moreover, the US FDA recalls products that pose potential health risks to users due to manufacturing defects. wrong reported vitamin D levels can lead to inaccurate vitamin supplement dosages and can lead to serious health problems. Additionally, recall occurrences can become pitfalls and lead to a significant loss for vendors,  which will be impeding the growth of the market during the forecast period.

Buy Now Full Report and Discover More

Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Market Customer Landscape

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Beckman Coulter Inc.: The company offers vitamin D testing solution namely Access 25(OH) Vitamin D Total Assay

• Biohit Oyj
• bioMerieux SA
• BioVendor Laboratorni medicina AS
• Boditech Med Inc.
• DiaSorin SpA
• DiaSys Diagnostic Systems GmbH
• Everly Health Inc.
• F. Hoffmann La Roche Ltd.
• Laboratory Corp. of America Holdings
• Perkin Elmer Inc.
• Qualigen Therapeutics Inc.
• Quest Diagnostics Inc.
• Quidelortho Corp.
• Randox Laboratories Ltd.
• Recipe Chemicals and Instruments GmbH
• Siemens AG
• Tecan Trading AG
• Thermo Fisher Scientific Inc.
• Tosoh Corp.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companiesas pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

• Product Outlook 
  • 25-hydroxyvitamin D testing
  • 1 25-dihydroxyvitamin D testing

• End-user Outlook
  • Diagnostic laboratories
  • Hospitals and physician clinics
  • Home care settings

• Region Outlook
  • North America
    • The U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Rest of the world
    • Brazil
    • Argentina
    • Australia

Maret Analyst Overview:

The market is experiencing a surge in demand, driven by factors such as the rising prevalence of chronic kidney disease (CKD) and the growing awareness of the importance of 25 hydroxy vitamin D levels. With hospitals, clinics, and standalone clinical laboratories offering testing services, the market caters to various healthcare settings. Deficiencies in vitamin D can lead to various health issues, including fatigue, muscle twitching, and bone changes, making early diagnosis crucial for effective treatment. Technological advancements have led to the development of plasma serum tests with improved accuracy, supported by private agencies and health organizations promoting preventive healthcare. The market's global presence is expanding, driven by new market initiatives and product launches aimed at addressing application dominance and increasing production capacities.

Further, the market is witnessing a surge in demand for 25 hydroxy vitamin D testing, especially in hospitals and clinics, driven by growing awareness of its crucial role in immune system regulation. As a fat-soluble steroid prohormone, vitamin D is essential for calcium, magnesium, and phosphate absorption, impacting overall health. Deficiency can lead to various issues like depression, irritability, and fractures, particularly affecting infants and pregnant women. Diagnostic tests play a vital role in identifying deficiencies, prompting health organizations and healthcare authorities to organize awareness events. With a half-life and technological advancements, the market anticipates new product launches to address growing health concerns related to vitamin D deficiency.

Market Scope
Report Coverage	Details
Page number	163
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 5.44%
Market growth 2023-2027	USD 193.53 million
Market structure	Fragmented
YoY growth 2022-2023(%)	4.5
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 38%
Key countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
Key companies profiled	Beckman Coulter Inc., Biohit Oyj, bioMerieux SA, BioVendor Laboratorni medicina AS, Boditech Med Inc., DiaSorin SpA, DiaSys Diagnostic Systems GmbH, Everly Health Inc., F. Hoffmann La Roche Ltd., Laboratory Corp. of America Holdings, Perkin Elmer Inc., Qualigen Therapeutics Inc., Quest Diagnostics Inc., Quidelortho Corp., Randox Laboratories Ltd., Recipe Chemicals and Instruments GmbH, Siemens AG, Tecan Trading AG, Thermo Fisher Scientific Inc., and Tosoh Corp.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
• Precise estimation of the market size and its contribution to the parent market
• Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch